Specialists for Acquired cystic disease-associated renal cell carcinoma

60 physicians and care centers identified from ClinicalTrials.gov trial PIs, PubMed publications, and the NPPES NPI registry.

ℹ

Specialists are identified from ClinicalTrials.gov principal investigators, PubMed publications, and the NPI registry, then ranked through an automated scoring pipeline.

Report missing data

Sylvie NEGRIER, PhD
Rare Disease / Clinical Research
Centre Leon Berard
QC-verified PI×3
Fangjian Zhou, Professor
Rare Disease / Clinical Research
Director of Dept. of Urology, Sun Yat-sen University Cancer Center
QC-verified PI×2
Sumanta K Pal, MD
Rare Disease / Clinical Research
City of Hope Medical Center
DUARTE, CA
QC-verified PI×7 25
Bo Shen, MD
Rare Disease / Clinical Research
Clevland Clinic
CLEVELAND, OH
PI×3
Eric Jonasch, MD, M.D
Rare Disease / Clinical Research
M.D. Anderson Cancer Center
HOUSTON, TX
PI×14
Toni K Choueiri, MD, M.D
Rare Disease / Clinical Research
Dana-Farber Cancer Institute
BOSTON, MA
PI×5
Daniel George, MD
Rare Disease / Clinical Research
Duke University
PI×4
Giuseppe Procopio, MD, R. Ph
Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy
PI×9 1
Andrea B Apolo, M.D., MD
Rare Disease / Clinical Research
National Cancer Institute (NCI)
BETHESDA, MD
PI×9
John D. Hainsworth, MD, MD
Rare Disease / Clinical Research
SCRI Development Innovations, LLC
NASHVILLE, TN
PI×11
Robert J. Motzer, MD, MD
Rare Disease / Clinical Research
Memorial Sloan Kettering Cancer Center
NEW YORK, NY
PI×10
Matthew T Campbell
Rare Disease / Clinical Research
M.D. Anderson Cancer Center
PI×2 107
Matthew B. Rettig, MD, MD
Rare Disease / Clinical Research
VA Greater Los Angeles Healthcare System, West Los Angeles, CA
LOS ANGELES, CA
PI×3
Steven A Rosenberg, M.D.
Rare Disease / Clinical Research
National Cancer Institute (NCI)
PI×22
Jane Robertson
Rare Disease / Clinical Research
AstraZeneca
PI×3 38
Armando Santoro, MD
Rare Disease / Clinical Research
Istituto Clinico Humanitas
PI×19
Dan Zandberg, MD, MD
Rare Disease / Clinical Research
UPMC Hillman Cancer Center
BALTIMORE, MD
PI×2
Naomi S. Balzer-Haas, MD
Rare Disease / Clinical Research
Abramson Cancer Center at Penn Medicine
PI×2
Rahul Aggarwal, MD
Rare Disease / Clinical Research
University of California, San Francisco
PI×6
Harriet Kluger, MD, MD
Rare Disease / Clinical Research
Yale University
NEW HAVEN, CT
PI×4
Shancheng Ren, MD,PhD
Rare Disease / Clinical Research
Shanghai Changzheng Hospital
PI×2
Tanya Dorff, M.D
Rare Disease / Clinical Research
City of Hope Comprehensive Cancer Center
DUARTE, CA
PI×2 1
Thomas A Waldmann, M.D.
Rare Disease / Clinical Research
National Cancer Institute (NCI)
PI×6
Brian Rini, MD, MD
Rare Disease / Clinical Research
Vanderbilt-Ingram Cancer Center
NASHVILLE, TN
PI×4
Roger Strair, MD, PhD, MD
Rare Disease / Clinical Research
Rutgers Cancer Institute of New Jersey
CAMDEN, NJ
PI×10
Jennifer Johnson, MD, PhD
Rare Disease / Clinical Research
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University
PI×6
Matthew D Galsky
Rare Disease Specialist
City of Hope Comprehensive Cancer Center
Duarte, California
PI×2
Rahul R Aggarwal
Yale University Cancer Center LAO
QC-verified PI×1
John P. Hanson
St. Luke's Medical Center
QC-verified PI×1
Mamta Parikh, PharmD
City of Hope Comprehensive Cancer Center LAO
RED BANK, NJ
QC-verified PI×2
WJG Oyen
Department of Nuclear Medicine, Radboud University Nijmegen Medical Center, Nijmegen, The Netherlands
QC-verified PI×1
Robert Figlin, md
Cedars-Sinai Medical Center
DUARTE, CA
QC-verified PI×1
Bernard Escudier, M.D
Gustave Roussy, Cancer Campus, Grand Paris
QC-verified PI×1
Carmine Pinto
Gruppo Oncologico Italiano di Ricerca Clinica
QC-verified PI×2
Elaina Gartner, MD
Seagen Inc.
DETROIT, MI
QC-verified PI×2
Hongqian Guo
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
QC-verified PI×3
Haitao Niu
The Affiliated Hospital of Qingdao University
QC-verified PI×2
Chaitanya Divgi, MD
University of Pennsylvania
NEW YORK, NY
QC-verified PI×2
Dr Mohammed Kamran
Future Genetics Limited
QC-verified PI×2
Antonio Finelli
University Health Network, Toronto
QC-verified PI×2
Johanna Bendell, M.D
SCRI Development Innovations, LLC
NASHVILLE, TN
QC-verified PI×3
Brian H. Kushner, MD
Memorial Sloan Kettering Cancer Center
NEW YORK, NY
QC-verified PI×5
Ronald Bukowski, md
The Cleveland Clinic
CLEVELAND, OH
QC-verified PI×1
Martin H Voss, MD
Memorial Sloan Kettering Cancer Center
EAU CLAIRE, WI
QC-verified PI×1
Michael Staehler, PD
Ludwig-Maximilians-Universität München, Klinikum Grosshadern
QC-verified PI×1
William Kim
UNC Lineberger Comprehensive Cancer Center
QC-verified PI×1
SEVIN Emmanuel
Centre François Baclesse
QC-verified PI×1
Catherine RIOUFOL
Hospices Civils de Lyon
QC-verified PI×1
Ismail B Turkbey
National Cancer Institute (NCI)
BETHESDA, MD
QC-verified PI×1
Giuseppe Di Lorenzo
QC-verified PI×1
Samuel Z. Goldhaber
Brigham and Women's Hospital
BOSTON, MA
QC-verified PI×1
Andrew Gunn
University of Alabama at Birmingham
QC-verified PI×1
Alain Manrique
University Hospital, Rouen
QC-verified PI×1
Karen E. Steinhauser
Durham VA Medical Center HSR&D COE
QC-verified PI×1
Vichien Srimuninnimit, Ass.Prof.
Siriraj Hospital, Bangkok, Thailand
QC-verified PI×1
Mark R. Middleton
The Christie NHS Foundation Trust
QC-verified PI×1
peng chen
Department of Pulmonary Medical Oncology, Tianjin Medical University Cancer Hospital
QC-verified PI×1
Jean-Christophe BERNHARD, Dr
University Hospital Bordeaux, France
QC-verified PI×1
Jianchuan Xia
Sun Yat-sen University
QC-verified PI×1
David Avigan, M.D
Beth Israel Deaconess Medical Center
QC-verified PI×2

More about Acquired cystic disease-associated renal cell carcinoma

Disease overview →
Treatments →
Clinical trials →